WASHINGTON — The price may be high but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
By KRISTA LARSON and MARIA CHENG, Associated Press
July 28, 2014 11:41 a.m.
DAKAR, Senegal — No one knows for sure just how many people Patrick Sawyer came into contact with the day he boarded a plane in Liberia, had a layover in Togo and then arrived in Nigeria where authorities say he died days later from Ebola, one of the world's deadliest diseases.